Panagiotis Bouris

703 total citations
11 papers, 590 citations indexed

About

Panagiotis Bouris is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Panagiotis Bouris has authored 11 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Panagiotis Bouris's work include Protease and Inhibitor Mechanisms (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Panagiotis Bouris is often cited by papers focused on Protease and Inhibitor Mechanisms (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Panagiotis Bouris collaborates with scholars based in Greece, Sweden and United States. Panagiotis Bouris's co-authors include Nikos K. Karamanos, Achilleas D. Theocharis, Spyros S. Skandalis, Alexios J. Aletras, Zoi Piperigkou, Aristidis Moustakas, Nikolaos A. Afratis, Dimitra Manou, Κωνσταντίνα Καραμάνου and Renato V. Iozzo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Panagiotis Bouris

11 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Panagiotis Bouris Greece 11 288 197 185 165 103 11 590
Yin Xu United States 11 600 2.1× 169 0.9× 230 1.2× 173 1.0× 80 0.8× 15 858
Virginia Ladeda Argentina 11 345 1.2× 166 0.8× 163 0.9× 134 0.8× 39 0.4× 12 584
Ludmila Szabova United States 13 325 1.1× 72 0.4× 241 1.3× 249 1.5× 83 0.8× 21 682
Cheryl McFarlane United Kingdom 14 460 1.6× 132 0.7× 246 1.3× 128 0.8× 39 0.4× 19 680
Stefano Marastoni Italy 9 302 1.0× 78 0.4× 110 0.6× 113 0.7× 50 0.5× 14 522
Brian J. Grindel United States 13 273 0.9× 175 0.9× 78 0.4× 78 0.5× 43 0.4× 21 486
Gina L. Razidlo United States 15 512 1.8× 187 0.9× 204 1.1× 114 0.7× 33 0.3× 23 789
Jennifer L. Brockman United States 11 432 1.5× 178 0.9× 251 1.4× 63 0.4× 122 1.2× 13 683
Marta C. Guadamillas Spain 7 447 1.6× 303 1.5× 183 1.0× 182 1.1× 24 0.2× 8 763
Michelle Burrows United States 11 423 1.5× 186 0.9× 75 0.4× 231 1.4× 32 0.3× 13 748

Countries citing papers authored by Panagiotis Bouris

Since Specialization
Citations

This map shows the geographic impact of Panagiotis Bouris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panagiotis Bouris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panagiotis Bouris more than expected).

Fields of papers citing papers by Panagiotis Bouris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panagiotis Bouris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panagiotis Bouris. The network helps show where Panagiotis Bouris may publish in the future.

Co-authorship network of co-authors of Panagiotis Bouris

This figure shows the co-authorship network connecting the top 25 collaborators of Panagiotis Bouris. A scholar is included among the top collaborators of Panagiotis Bouris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panagiotis Bouris. Panagiotis Bouris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Manou, Dimitra, Panagiotis Bouris, Dimitris Kletsas, et al.. (2020). Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential. SHILAP Revista de lepidopterología. 6-7. 100033–100033. 13 indexed citations
2.
Manou, Dimitra, Ilaria Caon, Panagiotis Bouris, et al.. (2019). The Complex Interplay Between Extracellular Matrix and Cells in Tissues. Methods in molecular biology. 1952. 1–20. 106 indexed citations
3.
Bouris, Panagiotis, Dimitra Manou, Aristidis Moustakas, et al.. (2018). Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling. Matrix Biology. 74. 35–51. 54 indexed citations
4.
Afratis, Nikolaos A., Panagiotis Bouris, Spyros S. Skandalis, et al.. (2017). IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules. Scientific Reports. 7(1). 40138–40138. 35 indexed citations
5.
Piperigkou, Zoi, Panagiotis Bouris, Maurizio Onisto, et al.. (2016). Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules. Matrix Biology. 56. 4–23. 69 indexed citations
6.
Piperigkou, Zoi, Κωνσταντίνα Καραμάνου, Nikolaos A. Afratis, et al.. (2015). Biochemical and toxicological evaluation of nano-heparins in cell functional properties, proteasome activation and expression of key matrix molecules. Toxicology Letters. 240(1). 32–42. 19 indexed citations
7.
Daoussis, Dimitrios, Stamatis‐Nick C. Liossis, Chaido Sirinian, et al.. (2015). Anti-TNFα treatment decreases the previously increased serum Indian Hedgehog levels in patients with ankylosing spondylitis and affects the expression of functional Hedgehog pathway target genes. Seminars in Arthritis and Rheumatism. 44(6). 646–651. 13 indexed citations
8.
Bouris, Panagiotis, Spyros S. Skandalis, Zoi Piperigkou, et al.. (2015). Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells. Matrix Biology. 43. 42–60. 145 indexed citations
9.
Papachristou, Dionysios J., et al.. (2015). Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines. BioMed Research International. 2015. 1–10. 29 indexed citations
10.
Bouris, Panagiotis, et al.. (2014). EGFR and HER2 exert distinct roles on colon cancer cell functional properties and expression of matrix macromolecules. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(8). 2651–2661. 23 indexed citations
11.
Theocharis, Achilleas D., Chrysostomi Gialeli, Panagiotis Bouris, et al.. (2014). Cell–matrix interactions: focus on proteoglycan–proteinase interplay and pharmacological targeting in cancer. FEBS Journal. 281(22). 5023–5042. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026